PI3K/AKT/mTOR/SREBP2 pathway is upregulated by VHL mutations and the subsequent stabilization of HIFα, contributing to the accumulation of intracellular cholesteryl esters and facilitating ccRCC development (Zhang et al., 2024). Here, SREBF2 is linked to nonpapillary renal cell carcinoma.